[ad_1]
Photo: David Zalubowski / AP
At Johnson & Johnson’s US plant, 15 million doses of vaccine were spoiled due to human factors
US officials have high hopes that Johnson & Johnson’s single-dose vaccine will accelerate the nation’s vaccination program.
Employees at the US Johnson & Johnson plant in Baltimore made a mistake mixing the ingredients for a vaccine against a new type of coronavirus infection, resulting in the loss of 15 million doses of the drug. On Wednesday, March 31, writes The New York Times.
Due to the incident, the United States Food and Drug Administration (FDA) is conducting an inspection of the plant. At the same time, it is noted that all batches of the company’s vaccine that have already reached medical institutions in the US are safe as they were produced at Johnson & Johnson’s facilities in the Netherlands; however, subsequent batches of the drug were planned to be shipped from the Baltimore plant, causing a delay in deliveries due to downtime due to FDA inspection.
We recall, the FDA at the end of February approved the appeal of the Janssen company, owned by the American corporation Johnson & Johnson, regarding the registration of its vaccine against the new coronavirus under the accelerated procedure in emergency circumstances.
Remember that Pfizer and BioNTech have begun testing their vaccine against coronavirus infection in children under 12 years of age to expand the use of the drug to this age group in early 2022.
News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet
